Sims Kyle, Montgomery Harold R, Dituro Paul, Kheirabadi Bijan S, Butler Frank K
J Spec Oper Med. 2016 Spring;16(1):19-28.
Exsanguination from wounds in the so-called junctional regions of the body (i.e., the neck, the axilla, and the groin) was responsible for 19% of the combat fatalities who died from potentially survivable wounds sustained in Afghanistan or Iraq during 2001 to 2011. The development of improved techniques and technology to manage junctional hemorrhage has been identified in the past as a high-priority item by the Committee on Tactical Combat Casualty Care (CoTCCC) and the Army Surgeon General's Dismounted Complex Blast Injury (DCBI) Task Force. Additionally, prehospital care providers have had limited options with which to manage hemorrhage resulting from deep, narrow-track, penetrating trauma. XStat™ is a new product recently approved by the US Food and Drug Administration as a hemostatic adjunct to aid in the control of bleeding from junctional wounds in the groin or axilla. XStat has now been recommended by the CoTCCC as another tool for the combat medical provider to use in the management of junctional hemorrhage. The evidence that supports adding XStat to the TCCC Guidelines for the treatment of external hemorrhage is summarized in this paper.
2001年至2011年期间，在阿富汗或伊拉克因潜在可救治伤口而死亡的战斗人员中，有19%是死于身体所谓的交界区域（即颈部、腋窝和腹股沟）的伤口出血。过去，战术战斗伤救治委员会（CoTCCC）和陆军军医总监的徒步复杂爆炸伤（DCBI）特别工作组已将开发改进的技术和工艺以控制交界区域出血确定为高度优先事项。此外，院前护理人员在处理因深部、窄道穿透性创伤导致的出血方面选择有限。XStat™是美国食品药品监督管理局最近批准的一种新产品，作为一种止血辅助工具，用于帮助控制腹股沟或腋窝交界区域伤口的出血。现在，CoTCCC已推荐XStat作为战斗医疗人员管理交界区域出血的另一种工具。本文总结了支持将XStat添加到TCCC外部出血治疗指南中的证据。
